Literature DB >> 18599479

An interaction between the human T cell leukemia virus type 1 basic leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the down-regulation of tax-dependent viral transcription by HBZ.

Isabelle Clerc1, Nicholas Polakowski, Charlotte André-Arpin, Pamela Cook, Benoit Barbeau, Jean-Michel Mesnard, Isabelle Lemasson.   

Abstract

Activation of human T cell leukemia virus type 1 (HTLV-1) transcription is established through the formation of protein complexes on the viral promoter that are essentially composed of the cellular basic leucine zipper (bZIP) transcription factor cAMP-response element-binding protein (CREB (or certain other members of the ATF/CREB family), the HTLV-1-encoded transactivator Tax, and the pleiotropic cellular coactivators p300/CBP. HTLV-1 bZIP factor (HBZ) is a protein encoded by HTLV-1 that contains a bZIP domain and functions to repress HTLV-1 transcription. HBZ has been shown to repress viral transcription by dimerizing with CREB, which occurs specifically through the bZIP domain in each protein, and preventing CREB from binding to the DNA. However, we previously found that HBZ causes only partial removal of CREB from a chromosomally integrated viral promoter, and more importantly, an HBZ mutant lacking the COOH-terminal bZIP domain retains the ability to repress viral transcription. These results suggest that an additional mechanism contributes to HBZ-mediated repression of HTLV-1 transcription. In this study, we show that HBZ binds directly to the p300 and CBP coactivators. Two LXXLL-like motifs located within the NH(2)-terminal region of HBZ are important for this interaction and specifically mediate binding to the KIX domain of p300/CBP. We provide evidence that this interaction interferes with the ability of Tax to bind p300/CBP and thereby inhibits the association of the coactivators with the viral promoter. Our findings demonstrate that HBZ utilizes a bipartite mechanism to repress viral transcription.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18599479      PMCID: PMC3259792          DOI: 10.1074/jbc.M803116200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  65 in total

Review 1.  Transcriptional and post-transcriptional gene regulation of HTLV-1.

Authors:  Fatah Kashanchi; John N Brady
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

2.  Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct motifs.

Authors:  Patrick Hivin; Mélissa Frédéric; Charlotte Arpin-André; Jihane Basbous; Bernard Gay; Sabine Thébault; Jean-Michel Mesnard
Journal:  J Cell Sci       Date:  2005-03-08       Impact factor: 5.285

3.  E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells.

Authors:  Richard Bayly; Luan Chuen; Richard A Currie; Brandy D Hyndman; Richard Casselman; Gerd A Blobel; David P LeBrun
Journal:  J Biol Chem       Date:  2004-10-26       Impact factor: 5.157

4.  Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein.

Authors:  Jean-Marie Peloponese; Kerstin Haller; Akiko Miyazato; Kuan-Teh Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

5.  Association of p300 and CBP with simian virus 40 large T antigen.

Authors:  R Eckner; J W Ludlow; N L Lill; E Oldread; Z Arany; N Modjtahedi; J A DeCaprio; D M Livingston; J A Morgan
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

6.  Tax oncoprotein of HTLV-1 binds to the human homologue of Drosophila discs large tumor suppressor protein, hDLG, and perturbs its function in cell growth control.

Authors:  T Suzuki; Y Ohsugi; M Uchida-Toita; T Akiyama; M Yoshida
Journal:  Oncogene       Date:  1999-10-28       Impact factor: 9.867

7.  Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates.

Authors:  W L Kraus; E T Manning; J T Kadonaga
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

8.  HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.

Authors:  Yorifumi Satou; Jun-ichirou Yasunaga; Mika Yoshida; Masao Matsuoka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

9.  The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.

Authors:  D Patel; S M Huang; L A Baglia; D J McCance
Journal:  EMBO J       Date:  1999-09-15       Impact factor: 11.598

10.  Activation of HTLV-I gene transcription by protein tyrosine phosphatase inhibitors.

Authors:  Mélanie Langlois; Brigitte Audet; Eric Legault; Marie-Eve Paré; Michel Ouellet; Jocelyn Roy; Nancy Dumais; Jean-Michel Mesnard; David M Rothstein; Susan J Marriott; Michel J Tremblay; Benoit Barbeau
Journal:  Virology       Date:  2004-11-24       Impact factor: 3.616

View more
  83 in total

Review 1.  Molecular mechanisms of HTLV-1 infection and pathogenesis.

Authors:  Junichiro Yasunaga; Masao Matsuoka
Journal:  Int J Hematol       Date:  2011-09-28       Impact factor: 2.490

2.  Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits.

Authors:  Valerio W Valeri; Anna Hryniewicz; Vibeke Andresen; Kathy Jones; Claudio Fenizia; Izabela Bialuk; Hye Kyung Chung; Risaku Fukumoto; Robyn Washington Parks; Maria Grazia Ferrari; Christophe Nicot; Valentina Cecchinato; Frank Ruscetti; Genoveffa Franchini
Journal:  Blood       Date:  2010-07-20       Impact factor: 22.113

3.  HBZ-mediated shift of JunD from growth suppressor to tumor promoter in leukemic cells by inhibition of ribosomal protein S25 expression.

Authors:  M Terol; H Gazon; I Lemasson; M Duc-Dodon; B Barbeau; R Césaire; J-M Mesnard; J-M Péloponèse
Journal:  Leukemia       Date:  2017-03-06       Impact factor: 11.528

4.  HTLV-1 HBZ protein deregulates interactions between cellular factors and the KIX domain of p300/CBP.

Authors:  Pamela R Cook; Nicholas Polakowski; Isabelle Lemasson
Journal:  J Mol Biol       Date:  2011-04-08       Impact factor: 5.469

Review 5.  Human T-lymphotropic virus proteins and post-translational modification pathways.

Authors:  Carlo Bidoia
Journal:  World J Virol       Date:  2012-08-12

6.  Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.

Authors:  Vibeke Andresen; Cynthia A Pise-Masison; Uma Sinha-Datta; Marcia Bellon; Valerio Valeri; Robyn Washington Parks; Valentina Cecchinato; Risaku Fukumoto; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2011-06-15       Impact factor: 22.113

7.  Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription.

Authors:  Marilène Halin; Estelle Douceron; Isabelle Clerc; Chloé Journo; Nga Ling Ko; Sébastien Landry; Edward L Murphy; Antoine Gessain; Isabelle Lemasson; Jean-Michel Mesnard; Benoît Barbeau; Renaud Mahieux
Journal:  Blood       Date:  2009-07-14       Impact factor: 22.113

8.  Biophysical analysis of HTLV-1 particles reveals novel insights into particle morphology and Gag stochiometry.

Authors:  Iwen F Grigsby; Wei Zhang; Jolene L Johnson; Keir H Fogarty; Yan Chen; Jonathan M Rawson; Aaron J Crosby; Joachim D Mueller; Louis M Mansky
Journal:  Retrovirology       Date:  2010-09-20       Impact factor: 4.602

Review 9.  The HBZ gene, a key player in HTLV-1 pathogenesis.

Authors:  Masao Matsuoka; Patrick L Green
Journal:  Retrovirology       Date:  2009-08-03       Impact factor: 4.602

Review 10.  Mechanisms of HTLV-1 persistence and transformation.

Authors:  M Boxus; L Willems
Journal:  Br J Cancer       Date:  2009-09-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.